lung cancer
Conditions
Interventions
1: Perfusion Scintigraphy
2:Three-dimensional reconstruction of chest CT
Sponsors
Department of Thoracic Surgery, the Fifth Affiliated Hospital of Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Voluntarily sign informed consent; 2. Lung cancer patients who underwent pulmonary resection again after MDT discussion and evaluation in our hospital; 3. Older than 18 years of age, equal to or less than 75 years of age.
Exclusion criteria
Exclusion criteria: 1. Patients with pulmonary embolism and bronchial asthma; 2. Pregnant or lactating women; A history of severe allergy or allergy to contrast agent (99MTC-MAA); 3. Any unstable systemic disease, including active infection, left and right shunt congenital heart disease, pulmonary arteriovenous fistula and severe lung damage, uncontrolled hypertension, unstable angina, myocardial infarction (6 months), heart function failure (cardiac function grade III or above), severe arrhythmia, severe liver and kidney disease; 4. Severe blood system and related diseases, such as severe granulocytopenia and platelets Hypoxia and aplastic anemia; 5. Neurological and related diseases; 6. Participants in drug clinical trials within the last 3 months; 7. MDT discussion determined that the patient was not suitable for inclusion. These include advanced tumors, atelectasis, and encapsulated pleural effusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postoperative FEV1;Prediction of Postoperative Forced Expiratory Volume in 1 Sec (FEV1) by Perfusion Scintigraphy;Prediction of Postoperative Forced Expiratory Volume in 1 Sec (FEV1) by Three-dimensional reconstruction of chest CT; | — |
Countries
China
Contacts
Public ContactQingdong Cao
the Fifth Affiliated Hospital of Sun Yat-sen University
Outcome results
None listed